Literature DB >> 20561830

Determination of vinpocetine and its primary metabolite, apovincaminic acid, in rat plasma by liquid chromatography-tandem mass spectrometry.

Hui-Min Xia1, Li-Na Su, Jian-Wei Guo, Guang-Ming Liu, Zhi-Qing Pang, Xin-Guo Jiang, Jun Chen.   

Abstract

A precise and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of vinpocetine (VP) and its primary metabolite, apovincaminic acid (AVA), in rat plasma was developed and validated. The analytes and the internal standard-dimenhydrinate were extracted from 50 microL aliquots of rat plasma via solid-liquid extraction. Chromatographic separation was achieved in a run time of 3.5 min on a C(18) column under isocratic conditions. Detection of analytes and IS was done by tandem mass spectrometry, operating in positive ion and multiple reaction monitoring (MRM) acquisition mode. The protonated precursor to product ion transitions monitored for VP, AVA and IS were m/z 351.4-->280.2, 323.2-->280.2 and 256.2-->167.3 respectively. The method was fully validated for its sensitivity, selectivity, accuracy and precision, matrix effect, stability study and dilution integrity. A linear dynamic range of 0.5-500 ng/mL for both VP and AVA was evaluated with mean correlation coefficient (r) of 0.9970 and 0.9984 respectively. The precision of the assay (RSD%) was less than 8.55% at all concentrations levels for both VP and AVA. This method was successfully applied to a pharmacokinetic study of VP in rats after intravenous (1 mg/kg) and oral (1 mg/kg) administration. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561830     DOI: 10.1016/j.jchromb.2010.05.029

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Embryo-fetal development studies with the dietary supplement vinpocetine in the rat and rabbit.

Authors:  Natasha Catlin; Suramya Waidyanatha; Eve Mylchreest; Lutfiya Miller-Pinsler; Helen Cunny; Paul Foster; Vicki Sutherland; Barry McIntyre
Journal:  Birth Defects Res       Date:  2018-02-19       Impact factor: 2.344

2.  Systemic exposure of vinpocetine in pregnant Sprague Dawley rats following repeated oral exposure: An investigation of fetal transfer.

Authors:  Suramya Waidyanatha; Heather Toy; Natalie South; Seth Gibbs; Esra Mutlu; Brian Burback; Barry S McIntyre; Natasha Catlin
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-15       Impact factor: 4.219

3.  Surface-tailoring of emulsomes for boosting brain delivery of vinpocetine via intranasal route: in vitro optimization and in vivo pharmacokinetic assessment.

Authors:  Hibah M Aldawsari; Shaimaa M Badr-Eldin; Nourah Y Assiri; Nabil A Alhakamy; Anna Privitera; Filippo Caraci; Giuseppe Caruso
Journal:  Drug Deliv       Date:  2022-08-08       Impact factor: 6.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.